XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share Based Payments (Tables)
3 Months Ended
May 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions used to Calculate Fair Value of Options on Date of Grant
The following assumptions were used to calculate the fair value of the Company’s options on the date of grant during the three months ended May 31, 2017 and 2018:
 
 
Three Months Ended May 31,
 
2017
 
2018
Risk-Free Interest Rate:
1.9%
 
2.6%
Expected Dividend Yield:
0%
 
0%
Expected Life (Years):
4.4
 
4.8
Expected Volatility:
52.9% - 53.1%
 
53.2%
Summary of Stock Options Outstanding and Activity
The following table presents a summary of the Company’s stock options outstanding at May 31, 2018, and stock option activity during the three months ended May 31, 2018 (“Price” reflects the weighted average exercise price per share; "Aggregate Intrinsic Value" dollars in thousands):
 
 
Options
 
Price
 
Weighted Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
Outstanding, beginning of period
2,691,329

 
$
4.66

 
 
 
 
Granted
84,000

 
4.16

 
 
 
 
Exercised
45,834

 
2.60

 
 
 
 
Forfeited

 

 
 
 
 
Expired
27,850

 
9.76

 
 
 
 
Outstanding, end of period
2,701,645

 
4.63

 
6.4
 
$
4,786

Exercisable, end of period
2,140,277

 
5.05

 
5.8
 
$
3,440


Summary of Nonvested Options and Changes
A summary of the Company’s nonvested options at May 31, 2018, and changes during the three months ended May 31, 2018, is presented below:
 
 
Options
 
Weighted Average
Grant Date
Fair Value
Nonvested, beginning of period
691,114

 
$
2.10

Granted
84,000

 
2.03

Vested
213,746

 
3.91

Forfeited

 

Nonvested, end of period
561,368

 
1.40

Summary of Restricted Stock Grants Outstanding and Activity
The following table presents a summary of the Company’s restricted stock grants outstanding at May 31, 2018, and restricted stock activity during the three months ended May 31, 2018 (“Price” reflects the weighted average share price at the date of grant):
 
 
Awards
 
Price
Grants outstanding, beginning of period
353,394

 
$
3.05

Granted
123,514

 
4.43

Vested (restriction lapsed)
36,015

 
4.42

Grants outstanding, end of period
440,893

 
3.32

Stock-Based Compensation Expense and Related Tax Benefits Recognized
The following table summarizes stock-based compensation expense recognized by the Company during the three months ended May 31, 2017 and 2018. The Company did not recognize any tax benefits related to stock-based compensation during the periods presented below. 
 
Three Months Ended May 31,
 
2017
 
2018
Station operating expenses
$
149

 
$
71

Corporate expenses
540

 
392

Stock-based compensation expense included in operating expenses
$
689

 
$
463